Blood Markers of Coagulation, Fibrinolysis, Endothelial Dysfunction and Inflammation in Lacunar Stroke versus Non-Lacunar Stroke and Non-Stroke: Systematic Review and Meta-Analysis
Background: The cause of cerebral small vessel disease is not fully understood, yet it is important, accounting for about 25% of all strokes. It also increases the risk of having another stroke and contributes to about 40% of dementias. Various processes have been implicated, including microatheroma...
Uloženo v:
| Vydáno v: | Cerebrovascular diseases (Basel, Switzerland) Ročník 37; číslo 1; s. 64 - 75 |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Basel, Switzerland
S. Karger AG
01.01.2014
|
| Témata: | |
| ISSN: | 1015-9770, 1421-9786, 1421-9786 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Background: The cause of cerebral small vessel disease is not fully understood, yet it is important, accounting for about 25% of all strokes. It also increases the risk of having another stroke and contributes to about 40% of dementias. Various processes have been implicated, including microatheroma, endothelial dysfunction and inflammation. A previous review investigated endothelial dysfunction in lacunar stroke versus mostly non-stroke controls while another looked at markers of inflammation and endothelial damage in ischaemic stroke in general. We have focused on blood markers between clinically evident lacunar stroke and other subtypes of ischaemic stroke, thereby controlling for stroke in general. Summary: We systematically assessed the literature for studies comparing blood markers of coagulation, fibrinolysis, endothelial dysfunction and inflammation in lacunar stroke versus non-stroke controls or other ischaemic stroke subtypes. We assessed the quality of included papers and meta-analysed results. We split the analysis on time of blood draw in relation to the stroke. We identified 1,468 full papers of which 42 were eligible for inclusion, including 4,816 ischaemic strokes, of which 2,196 were lacunar and 2,500 non-stroke controls. Most studies subtyped stroke using TOAST. The definition of lacunar stroke varied between studies. Markers of coagulation/fibrinolysis (tissue plasminogen activator (tPA), plasminogen activator inhibitor (PAI), fibrinogen, D-dimer) were higher in lacunar stroke versus non-stroke although fibrinogen was no different to non-stroke in the acute phase. tPA and PAI were no different between lacunar and non-lacunar stroke. Fibrinogen and D-dimer were significantly lower in lacunar stroke compared to other ischaemic strokes, both acutely and chronically. Markers of endothelial dysfunction (homocysteine, von Willebrand Factor (vWF), E-selectin, P-selectin, intercellular adhesion molecule-1 (ICAM), vascular cellular adhesion molecule-1 (VCAM)) were higher or had insufficient or conflicting data (P-selectin, VCAM) in lacunar stroke versus non-stroke. Compared to other ischaemic stroke subtypes, homocysteine did not differ in lacunar stroke while vWF was significantly lower in lacunar stroke acutely [atherothrombotic standardized mean difference, SMD, -0.34 (-0.61, -0.08); cardioembolic SMD -0.38 (-0.62, -0.14)], with insufficient data chronically. Markers of inflammation (C-reactive protein (CRP), tumour necrosis factor-alpha (TNF-α), interleukin-6 (IL-6)) were higher in lacunar stroke versus non-stroke, although there were no studies measuring TNF-α chronically and the sole study measuring IL-6 chronically showed no difference between lacunar stroke and non-stroke. Compared to other ischaemic stroke subtypes, there was no difference (CRP) or insufficient or conflicting data (TNF-α) to lacunar stroke. IL-6 was significantly lower [atherothrombotic SMD -0.37 (-0.63, -0.10); cardioembolic SMD -0.52 (-0.82, -0.22)] in lacunar stroke acutely, with insufficient data chronically. Key Messages: Lacunar stroke is an important stroke subtype. More studies comparing lacunar stroke to non-lacunar stroke specifically, rather than to non-stroke controls, are needed. Prospective studies with measurements taken well after the acute event are more likely to be helpful in determining pathogenesis. The available data in this review were limited and do not exclude the possibility that peripheral inflammatory processes including endothelial dysfunction are associated with lacunar stroke and cerebral small vessel disease. |
|---|---|
| AbstractList | The cause of cerebral small vessel disease is not fully understood, yet it is important, accounting for about 25% of all strokes. It also increases the risk of having another stroke and contributes to about 40% of dementias. Various processes have been implicated, including microatheroma, endothelial dysfunction and inflammation. A previous review investigated endothelial dysfunction in lacunar stroke versus mostly non-stroke controls while another looked at markers of inflammation and endothelial damage in ischaemic stroke in general. We have focused on blood markers between clinically evident lacunar stroke and other subtypes of ischaemic stroke, thereby controlling for stroke in general.BACKGROUNDThe cause of cerebral small vessel disease is not fully understood, yet it is important, accounting for about 25% of all strokes. It also increases the risk of having another stroke and contributes to about 40% of dementias. Various processes have been implicated, including microatheroma, endothelial dysfunction and inflammation. A previous review investigated endothelial dysfunction in lacunar stroke versus mostly non-stroke controls while another looked at markers of inflammation and endothelial damage in ischaemic stroke in general. We have focused on blood markers between clinically evident lacunar stroke and other subtypes of ischaemic stroke, thereby controlling for stroke in general.We systematically assessed the literature for studies comparing blood markers of coagulation, fibrinolysis, endothelial dysfunction and inflammation in lacunar stroke versus non-stroke controls or other ischaemic stroke subtypes. We assessed the quality of included papers and meta-analysed results. We split the analysis on time of blood draw in relation to the stroke. We identified 1,468 full papers of which 42 were eligible for inclusion, including 4,816 ischaemic strokes, of which 2,196 were lacunar and 2,500 non-stroke controls. Most studies subtyped stroke using TOAST. The definition of lacunar stroke varied between studies. Markers of coagulation/fibrinolysis (tissue plasminogen activator (tPA), plasminogen activator inhibitor (PAI), fibrinogen, D-dimer) were higher in lacunar stroke versus non-stroke although fibrinogen was no different to non-stroke in the acute phase. tPA and PAI were no different between lacunar and non-lacunar stroke. Fibrinogen and D-dimer were significantly lower in lacunar stroke compared to other ischaemic strokes, both acutely and chronically. Markers of endothelial dysfunction (homocysteine, von Willebrand Factor (vWF), E-selectin, P-selectin, intercellular adhesion molecule-1 (ICAM), vascular cellular adhesion molecule-1 (VCAM)) were higher or had insufficient or conflicting data (P-selectin, VCAM) in lacunar stroke versus non-stroke. Compared to other ischaemic stroke subtypes, homocysteine did not differ in lacunar stroke while vWF was significantly lower in lacunar stroke acutely [atherothrombotic standardized mean difference, SMD, -0.34 (-0.61, -0.08); cardioembolic SMD -0.38 (-0.62, -0.14)], with insufficient data chronically. Markers of inflammation (C-reactive protein (CRP), tumour necrosis factor-alpha (TNF-α), interleukin-6 (IL-6)) were higher in lacunar stroke versus non-stroke, although there were no studies measuring TNF-α chronically and the sole study measuring IL-6 chronically showed no difference between lacunar stroke and non-stroke. Compared to other ischaemic stroke subtypes, there was no difference (CRP) or insufficient or conflicting data (TNF-α) to lacunar stroke. IL-6 was significantly lower [atherothrombotic SMD -0.37 (-0.63, -0.10); cardioembolic SMD -0.52 (-0.82, -0.22)] in lacunar stroke acutely, with insufficient data chronically.SUMMARYWe systematically assessed the literature for studies comparing blood markers of coagulation, fibrinolysis, endothelial dysfunction and inflammation in lacunar stroke versus non-stroke controls or other ischaemic stroke subtypes. We assessed the quality of included papers and meta-analysed results. We split the analysis on time of blood draw in relation to the stroke. We identified 1,468 full papers of which 42 were eligible for inclusion, including 4,816 ischaemic strokes, of which 2,196 were lacunar and 2,500 non-stroke controls. Most studies subtyped stroke using TOAST. The definition of lacunar stroke varied between studies. Markers of coagulation/fibrinolysis (tissue plasminogen activator (tPA), plasminogen activator inhibitor (PAI), fibrinogen, D-dimer) were higher in lacunar stroke versus non-stroke although fibrinogen was no different to non-stroke in the acute phase. tPA and PAI were no different between lacunar and non-lacunar stroke. Fibrinogen and D-dimer were significantly lower in lacunar stroke compared to other ischaemic strokes, both acutely and chronically. Markers of endothelial dysfunction (homocysteine, von Willebrand Factor (vWF), E-selectin, P-selectin, intercellular adhesion molecule-1 (ICAM), vascular cellular adhesion molecule-1 (VCAM)) were higher or had insufficient or conflicting data (P-selectin, VCAM) in lacunar stroke versus non-stroke. Compared to other ischaemic stroke subtypes, homocysteine did not differ in lacunar stroke while vWF was significantly lower in lacunar stroke acutely [atherothrombotic standardized mean difference, SMD, -0.34 (-0.61, -0.08); cardioembolic SMD -0.38 (-0.62, -0.14)], with insufficient data chronically. Markers of inflammation (C-reactive protein (CRP), tumour necrosis factor-alpha (TNF-α), interleukin-6 (IL-6)) were higher in lacunar stroke versus non-stroke, although there were no studies measuring TNF-α chronically and the sole study measuring IL-6 chronically showed no difference between lacunar stroke and non-stroke. Compared to other ischaemic stroke subtypes, there was no difference (CRP) or insufficient or conflicting data (TNF-α) to lacunar stroke. IL-6 was significantly lower [atherothrombotic SMD -0.37 (-0.63, -0.10); cardioembolic SMD -0.52 (-0.82, -0.22)] in lacunar stroke acutely, with insufficient data chronically.Lacunar stroke is an important stroke subtype. More studies comparing lacunar stroke to non-lacunar stroke specifically, rather than to non-stroke controls, are needed. Prospective studies with measurements taken well after the acute event are more likely to be helpful in determining pathogenesis. The available data in this review were limited and do not exclude the possibility that peripheral inflammatory processes including endothelial dysfunction are associated with lacunar stroke and cerebral small vessel disease.KEY MESSAGESLacunar stroke is an important stroke subtype. More studies comparing lacunar stroke to non-lacunar stroke specifically, rather than to non-stroke controls, are needed. Prospective studies with measurements taken well after the acute event are more likely to be helpful in determining pathogenesis. The available data in this review were limited and do not exclude the possibility that peripheral inflammatory processes including endothelial dysfunction are associated with lacunar stroke and cerebral small vessel disease. The cause of cerebral small vessel disease is not fully understood, yet it is important, accounting for about 25% of all strokes. It also increases the risk of having another stroke and contributes to about 40% of dementias. Various processes have been implicated, including microatheroma, endothelial dysfunction and inflammation. A previous review investigated endothelial dysfunction in lacunar stroke versus mostly non-stroke controls while another looked at markers of inflammation and endothelial damage in ischaemic stroke in general. We have focused on blood markers between clinically evident lacunar stroke and other subtypes of ischaemic stroke, thereby controlling for stroke in general. We systematically assessed the literature for studies comparing blood markers of coagulation, fibrinolysis, endothelial dysfunction and inflammation in lacunar stroke versus non-stroke controls or other ischaemic stroke subtypes. We assessed the quality of included papers and meta-analysed results. We split the analysis on time of blood draw in relation to the stroke. We identified 1,468 full papers of which 42 were eligible for inclusion, including 4,816 ischaemic strokes, of which 2,196 were lacunar and 2,500 non-stroke controls. Most studies subtyped stroke using TOAST. The definition of lacunar stroke varied between studies. Markers of coagulation/fibrinolysis (tissue plasminogen activator (tPA), plasminogen activator inhibitor (PAI), fibrinogen, D-dimer) were higher in lacunar stroke versus non-stroke although fibrinogen was no different to non-stroke in the acute phase. tPA and PAI were no different between lacunar and non-lacunar stroke. Fibrinogen and D-dimer were significantly lower in lacunar stroke compared to other ischaemic strokes, both acutely and chronically. Markers of endothelial dysfunction (homocysteine, von Willebrand Factor (vWF), E-selectin, P-selectin, intercellular adhesion molecule-1 (ICAM), vascular cellular adhesion molecule-1 (VCAM)) were higher or had insufficient or conflicting data (P-selectin, VCAM) in lacunar stroke versus non-stroke. Compared to other ischaemic stroke subtypes, homocysteine did not differ in lacunar stroke while vWF was significantly lower in lacunar stroke acutely [atherothrombotic standardized mean difference, SMD, -0.34 (-0.61, -0.08); cardioembolic SMD -0.38 (-0.62, -0.14)], with insufficient data chronically. Markers of inflammation (C-reactive protein (CRP), tumour necrosis factor-alpha (TNF-α), interleukin-6 (IL-6)) were higher in lacunar stroke versus non-stroke, although there were no studies measuring TNF-α chronically and the sole study measuring IL-6 chronically showed no difference between lacunar stroke and non-stroke. Compared to other ischaemic stroke subtypes, there was no difference (CRP) or insufficient or conflicting data (TNF-α) to lacunar stroke. IL-6 was significantly lower [atherothrombotic SMD -0.37 (-0.63, -0.10); cardioembolic SMD -0.52 (-0.82, -0.22)] in lacunar stroke acutely, with insufficient data chronically. Lacunar stroke is an important stroke subtype. More studies comparing lacunar stroke to non-lacunar stroke specifically, rather than to non-stroke controls, are needed. Prospective studies with measurements taken well after the acute event are more likely to be helpful in determining pathogenesis. The available data in this review were limited and do not exclude the possibility that peripheral inflammatory processes including endothelial dysfunction are associated with lacunar stroke and cerebral small vessel disease. Background: The cause of cerebral small vessel disease is not fully understood, yet it is important, accounting for about 25% of all strokes. It also increases the risk of having another stroke and contributes to about 40% of dementias. Various processes have been implicated, including microatheroma, endothelial dysfunction and inflammation. A previous review investigated endothelial dysfunction in lacunar stroke versus mostly non-stroke controls while another looked at markers of inflammation and endothelial damage in ischaemic stroke in general. We have focused on blood markers between clinically evident lacunar stroke and other subtypes of ischaemic stroke, thereby controlling for stroke in general. Summary: We systematically assessed the literature for studies comparing blood markers of coagulation, fibrinolysis, endothelial dysfunction and inflammation in lacunar stroke versus non-stroke controls or other ischaemic stroke subtypes. We assessed the quality of included papers and meta-analysed results. We split the analysis on time of blood draw in relation to the stroke. We identified 1,468 full papers of which 42 were eligible for inclusion, including 4,816 ischaemic strokes, of which 2,196 were lacunar and 2,500 non-stroke controls. Most studies subtyped stroke using TOAST. The definition of lacunar stroke varied between studies. Markers of coagulation/fibrinolysis (tissue plasminogen activator (tPA), plasminogen activator inhibitor (PAI), fibrinogen, D-dimer) were higher in lacunar stroke versus non-stroke although fibrinogen was no different to non-stroke in the acute phase. tPA and PAI were no different between lacunar and non-lacunar stroke. Fibrinogen and D-dimer were significantly lower in lacunar stroke compared to other ischaemic strokes, both acutely and chronically. Markers of endothelial dysfunction (homocysteine, von Willebrand Factor (vWF), E-selectin, P-selectin, intercellular adhesion molecule-1 (ICAM), vascular cellular adhesion molecule-1 (VCAM)) were higher or had insufficient or conflicting data (P-selectin, VCAM) in lacunar stroke versus non-stroke. Compared to other ischaemic stroke subtypes, homocysteine did not differ in lacunar stroke while vWF was significantly lower in lacunar stroke acutely [atherothrombotic standardized mean difference, SMD, -0.34 (-0.61, -0.08); cardioembolic SMD -0.38 (-0.62, -0.14)], with insufficient data chronically. Markers of inflammation (C-reactive protein (CRP), tumour necrosis factor-alpha (TNF-α), interleukin-6 (IL-6)) were higher in lacunar stroke versus non-stroke, although there were no studies measuring TNF-α chronically and the sole study measuring IL-6 chronically showed no difference between lacunar stroke and non-stroke. Compared to other ischaemic stroke subtypes, there was no difference (CRP) or insufficient or conflicting data (TNF-α) to lacunar stroke. IL-6 was significantly lower [atherothrombotic SMD -0.37 (-0.63, -0.10); cardioembolic SMD -0.52 (-0.82, -0.22)] in lacunar stroke acutely, with insufficient data chronically. Key Messages: Lacunar stroke is an important stroke subtype. More studies comparing lacunar stroke to non-lacunar stroke specifically, rather than to non-stroke controls, are needed. Prospective studies with measurements taken well after the acute event are more likely to be helpful in determining pathogenesis. The available data in this review were limited and do not exclude the possibility that peripheral inflammatory processes including endothelial dysfunction are associated with lacunar stroke and cerebral small vessel disease. Background: The cause of cerebral small vessel disease is not fully understood, yet it is important, accounting for about 25% of all strokes. It also increases the risk of having another stroke and contributes to about 40% of dementias. Various processes have been implicated, including microatheroma, endothelial dysfunction and inflammation. A previous review investigated endothelial dysfunction in lacunar stroke versus mostly non-stroke controls while another looked at markers of inflammation and endothelial damage in ischaemic stroke in general. We have focused on blood markers between clinically evident lacunar stroke and other subtypes of ischaemic stroke, thereby controlling for stroke in general. Summary: We systematically assessed the literature for studies comparing blood markers of coagulation, fibrinolysis, endothelial dysfunction and inflammation in lacunar stroke versus non-stroke controls or other ischaemic stroke subtypes. We assessed the quality of included papers and meta-analysed results. We split the analysis on time of blood draw in relation to the stroke. We identified 1,468 full papers of which 42 were eligible for inclusion, including 4,816 ischaemic strokes, of which 2,196 were lacunar and 2,500 non-stroke controls. Most studies subtyped stroke using TOAST. The definition of lacunar stroke varied between studies. Markers of coagulation/fibrinolysis (tissue plasminogen activator (tPA), plasminogen activator inhibitor (PAI), fibrinogen, D-dimer) were higher in lacunar stroke versus non-stroke although fibrinogen was no different to non-stroke in the acute phase. tPA and PAI were no different between lacunar and non-lacunar stroke. Fibrinogen and D-dimer were significantly lower in lacunar stroke compared to other ischaemic strokes, both acutely and chronically. Markers of endothelial dysfunction (homocysteine, von Willebrand Factor (vWF), E-selectin, P-selectin, intercellular adhesion molecule-1 (ICAM), vascular cellular adhesion molecule-1 (VCAM)) were higher or had insufficient or conflicting data (P-selectin, VCAM) in lacunar stroke versus non-stroke. Compared to other ischaemic stroke subtypes, homocysteine did not differ in lacunar stroke while vWF was significantly lower in lacunar stroke acutely [atherothrombotic standardized mean difference, SMD, -0.34 (-0.61, -0.08); cardioembolic SMD -0.38 (-0.62, -0.14)], with insufficient data chronically. Markers of inflammation (C-reactive protein (CRP), tumour necrosis factor-alpha (TNF-α), interleukin-6 (IL-6)) were higher in lacunar stroke versus non-stroke, although there were no studies measuring TNF-α chronically and the sole study measuring IL-6 chronically showed no difference between lacunar stroke and non-stroke. Compared to other ischaemic stroke subtypes, there was no difference (CRP) or insufficient or conflicting data (TNF-α) to lacunar stroke. IL-6 was significantly lower [atherothrombotic SMD -0.37 (-0.63, -0.10); cardioembolic SMD -0.52 (-0.82, -0.22)] in lacunar stroke acutely, with insufficient data chronically. Key Messages: Lacunar stroke is an important stroke subtype. More studies comparing lacunar stroke to non-lacunar stroke specifically, rather than to non-stroke controls, are needed. Prospective studies with measurements taken well after the acute event are more likely to be helpful in determining pathogenesis. The available data in this review were limited and do not exclude the possibility that peripheral inflammatory processes including endothelial dysfunction are associated with lacunar stroke and cerebral small vessel disease. © 2013 S. Karger AG, Basel [PUBLICATION ABSTRACT] |
| Author | Wiseman, Stewart Webb, David J. Doubal, Fergus Wardlaw, Joanna Marlborough, Fergal |
| Author_xml | – sequence: 1 givenname: Stewart surname: Wiseman fullname: Wiseman, Stewart – sequence: 2 givenname: Fergal surname: Marlborough fullname: Marlborough, Fergal – sequence: 3 givenname: Fergus surname: Doubal fullname: Doubal, Fergus – sequence: 4 givenname: David J. surname: Webb fullname: Webb, David J. – sequence: 5 givenname: Joanna surname: Wardlaw fullname: Wardlaw, Joanna email: Joanna.Wardlaw@ed.ac.uk |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24401164$$D View this record in MEDLINE/PubMed |
| BookMark | eNptkc1u1DAUhS3Uiv7Agj1CltgUqaF24sQxu3ZoS6UpSBTWkWPfFHccu7WTVvNePCDOzLSLESsf-37n6MrnAO047wChd5R8prQUJ4SQoqx4LV6hfcpymgleVztJE1omzckeOojxLmEVrelrtJczRiit2D76e2a91_hahgWEiH2HZ17ejlYOxrtjfGHaYJy3y2jiMT532g9_wBpp8ddl7EanJgxLp_GV66zs-5UPG4fnUo1OBnwzBL8A_JjSx4i_e5dtTSbz9Ly-fsE3yzjAlKPwT3g08LQirmGQ2amTq03eoN1O2ghvN-ch-n1x_mv2LZv_uLyanc4zxQgZMkXzlkNBeUnLtmiZTIJp0KQoCOMi11BXbcGY7pTUgra6JBUXkueQ5yCAFofoaJ17H_zDCHFoehMVWCsd-DE2lImCi5oVPKEft9A7P4a0b6JKmpc1Y2wK_LChxrYH3dwH08uwbJ77SMDJGlDBxxiga5QZVn86BGlsQ0kzNd68NJ4cn7Ycz6H_Y9-v2YUMtxBeyM34H_hUtMM |
| CitedBy_id | crossref_primary_10_1186_s12974_023_02912_9 crossref_primary_10_1002_brb3_460 crossref_primary_10_1177_17562864241243274 crossref_primary_10_1159_000468994 crossref_primary_10_1161_STROKEAHA_114_005592 crossref_primary_10_3233_JAD_170733 crossref_primary_10_1161_JAHA_118_011104 crossref_primary_10_2174_0929867329666220921113403 crossref_primary_10_2217_bmm_2019_0537 crossref_primary_10_1159_000438494 crossref_primary_10_3390_ijms231911670 crossref_primary_10_1080_10408363_2018_1461190 crossref_primary_10_1097_QAD_0000000000001133 crossref_primary_10_1038_s41598_025_99742_x crossref_primary_10_1186_s12979_016_0074_z crossref_primary_10_3390_ijms23031497 crossref_primary_10_1111_ene_15704 crossref_primary_10_3389_fneur_2022_843953 crossref_primary_10_1080_1354750X_2017_1286689 crossref_primary_10_1161_STROKEAHA_115_012052 crossref_primary_10_3390_genes13091584 crossref_primary_10_3348_jksr_2022_0049 crossref_primary_10_1016_j_heliyon_2023_e23674 crossref_primary_10_1016_j_jstrokecerebrovasdis_2018_01_020 crossref_primary_10_1007_s12975_017_0584_9 crossref_primary_10_2196_resprot_4111 crossref_primary_10_1007_s10103_018_2485_x crossref_primary_10_3390_ijms23020912 crossref_primary_10_1016_j_bone_2014_11_007 crossref_primary_10_1159_000369777 crossref_primary_10_1212_CPJ_0000000000000419 crossref_primary_10_1289_EHP5751 crossref_primary_10_1161_JAHA_124_037577 crossref_primary_10_3390_ijms222212108 crossref_primary_10_1212_WNL_0000000000207242 crossref_primary_10_1007_s11481_017_9742_9 crossref_primary_10_1016_j_jstrokecerebrovasdis_2014_10_001 crossref_primary_10_1371_journal_pone_0133315 crossref_primary_10_1111_eci_12795 crossref_primary_10_1136_svn_2023_002791 crossref_primary_10_7717_peerj_14235 crossref_primary_10_1177_1747493017731947 crossref_primary_10_21518_ms2025_222 crossref_primary_10_1016_j_jstrokecerebrovasdis_2019_05_006 crossref_primary_10_1093_brain_awac290 crossref_primary_10_1093_cvr_cvy113 crossref_primary_10_3390_ijms17121967 crossref_primary_10_1177_00033197211030732 crossref_primary_10_1186_s40064_016_3090_8 crossref_primary_10_1177_1010539516650722 crossref_primary_10_3389_fneur_2019_00723 crossref_primary_10_1080_1354750X_2021_1923063 crossref_primary_10_3390_brainsci11020133 crossref_primary_10_1038_srep26053 crossref_primary_10_1016_j_bbrc_2017_11_205 crossref_primary_10_1016_j_clineuro_2019_105393 crossref_primary_10_1161_STROKEAHA_124_045903 crossref_primary_10_1371_journal_pone_0137142 crossref_primary_10_1177_1747493016641966 crossref_primary_10_1093_ecco_jcc_jjv042 crossref_primary_10_3389_fimmu_2018_01146 crossref_primary_10_24190_ISSN2564_615X_2017_02_09 crossref_primary_10_1016_j_jstrokecerebrovasdis_2019_02_023 crossref_primary_10_1111_odi_12360 crossref_primary_10_1007_s11055_024_01587_w crossref_primary_10_3390_jcm7110400 crossref_primary_10_3390_ijms241713114 crossref_primary_10_1177_17474930241273685 crossref_primary_10_1371_journal_pone_0116330 crossref_primary_10_1016_j_biomaterials_2023_122385 crossref_primary_10_1016_j_mvr_2020_104123 crossref_primary_10_1161_STROKEAHA_114_008010 crossref_primary_10_1016_j_jstrokecerebrovasdis_2015_07_010 crossref_primary_10_1007_s00415_025_12888_6 crossref_primary_10_1161_JAHA_123_031573 crossref_primary_10_1016_j_nbd_2024_106772 crossref_primary_10_1177_2396987318805905 crossref_primary_10_1161_STROKEAHA_116_014097 crossref_primary_10_1177_1747493019876538 crossref_primary_10_3389_fneur_2023_1170308 crossref_primary_10_1002_art_39287 crossref_primary_10_1016_j_jstrokecerebrovasdis_2017_03_002 crossref_primary_10_1007_s12017_019_08530_0 crossref_primary_10_1089_neur_2023_0044 crossref_primary_10_1007_s12031_021_01819_5 crossref_primary_10_1016_j_cellsig_2019_05_011 crossref_primary_10_1002_jnr_24353 crossref_primary_10_1016_j_clinbiochem_2021_07_003 crossref_primary_10_1007_s10238_021_00732_w crossref_primary_10_1186_s12883_017_0877_3 crossref_primary_10_1097_HJH_0000000000003503 crossref_primary_10_1111_ene_16443 crossref_primary_10_1016_j_cbpc_2015_07_012 crossref_primary_10_3389_fneur_2020_584695 crossref_primary_10_1002_ajh_25615 crossref_primary_10_1167_iovs_65_8_50 crossref_primary_10_1016_j_pjnns_2017_11_005 crossref_primary_10_3390_biomedicines11092398 crossref_primary_10_1007_s11926_020_00922_7 crossref_primary_10_1038_s41569_025_01130_5 crossref_primary_10_1038_hr_2016_157 crossref_primary_10_1007_s00774_025_01579_x crossref_primary_10_1016_j_bbrc_2016_04_042 crossref_primary_10_1093_cvr_cvaf138 crossref_primary_10_3390_bios7030030 crossref_primary_10_1371_journal_pone_0163409 crossref_primary_10_1016_j_ejpn_2018_01_018 crossref_primary_10_1371_journal_pone_0150740 crossref_primary_10_3390_jcdd12080281 crossref_primary_10_1016_j_jstrokecerebrovasdis_2016_08_007 crossref_primary_10_1016_j_neurol_2016_02_003 crossref_primary_10_1007_s12975_015_0424_8 |
| Cites_doi | 10.1161%2Fhs0402.105339 10.1161%2F01.STR.27.6.1066 10.1080%2F09537109876618 10.12659%2FMSM.881931 10.1161%2F01.STR.31.10.2325 10.1016%2Fj.atherosclerosis.2008.06.030 10.1161%2F01.STR.0000239694.19359.88 10.1016%2Fj.ejca.2005.03.032 10.1097%2FNRL.0b013e318198d8bc 10.1159%2F000214217 10.1016%2Fj.thromres.2011.02.020 10.1016%2Fj.jneuroim.2009.06.019 10.1001%2Farchinte.162.22.2589 10.1371%2Fjournal.pmed.1000097 10.1111%2Fj.1365-2125.2012.04212.x 10.1161%2FSTROKEAHA.107.505354 10.1161%2F01.STR.24.1.35 10.1016%2F0022-510X%2894%2990289-5 10.1159%2F000256652 10.1034%2Fj.1600-0404.2002.1o108.x 10.1161%2FSTROKEAHA.109.569855 10.4103%2F0256-4947.83217 10.1016%2Fj.thromres.2009.01.012 10.1016%2Fj.jns.2011.02.026 10.1161%2F01.CIR.0000131942.77635.2D 10.1161%2F01.STR.0000254500.27412.ac 10.1016%2Fj.clineuro.2011.01.016 10.1001%2Fjama.283.15.2008 10.1016%2FS0022-510X%2800%2900435-4 10.1016%2Fj.jocn.2006.11.012 10.1161%2F01.STR.31.5.1069 10.1126%2Fscitranslmed.3001249 10.1093%2Fbrain%2Fawh023 10.1111%2Fj.1538-7836.2010.04134.x 10.1111%2Fj.1538-7836.2008.02950.x 10.1161%2FSTROKEAHA.107.513416 10.1159%2F000332810 10.1016%2FS1474-4422%2813%2970124-8 10.1161%2F01.STR.23.2.194 10.1016%2Fj.cyto.2003.11.011 10.1161%2FSTROKEAHA.110.594754 10.1159%2F000212672 10.1161%2F01.STR.0000231872.86071.68 10.1161%2F01.STR.0000157949.34986.30 10.1002%2Fana.410370614 10.1016%2Fj.clineuro.2011.07.004 10.1177%2F0003319707304134 10.1016%2Fj.atherosclerosis.2011.03.001 10.1016%2Fj.jns.2009.06.032 10.1007%2Fs10072-004-0219-5 10.1016%2FS0021-9150%2801%2900635-9 10.1161%2F01.STR.0000183617.54752.69 10.1136%2Fjnnp.2010.230870 10.1016%2Fj.jns.2008.03.020 10.1093%2Fbrain%2Fawg040 10.1161%2F01.STR.24.12.1945 |
| ContentType | Journal Article |
| Copyright | 2013 S. Karger AG, Basel Copyright (c) 2014 S. Karger AG, Basel |
| Copyright_xml | – notice: 2013 S. Karger AG, Basel – notice: Copyright (c) 2014 S. Karger AG, Basel |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TK 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 |
| DOI | 10.1159/000356789 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Neurosciences Abstracts ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Proquest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef ProQuest One Academic Middle East (New) |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1421-9786 |
| EndPage | 75 |
| ExternalDocumentID | 3265764141 24401164 10_1159_000356789 356789 |
| Genre | Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review Journal Article |
| GrantInformation_xml | – fundername: Medical Research Council grantid: MR/K026992/1 |
| GroupedDBID | --- 0R~ 0~5 0~B 29B 30W 325 36B 3O. 3V. 4.4 53G 5GY 7X7 88E 8AO 8FI 8FJ 8UI AAYIC ABJNI ABPAZ ABUWG ACGFS ACPRK ACPSR ADAGL ADBBV ADGES AENEX AEYAO AFJJK AFKRA AHMBA ALDHI ALIPV ALMA_UNASSIGNED_HOLDINGS AZPMC BENPR BPHCQ BVXVI C45 CAG CCPQU COF CS3 CYUIP DU5 E0A EBS EJD EMB EMOBN F5P FB. FYUFA HMCUK HZ~ IAO IHR IHW IY7 KUZGX M1P N9A O1H O9- OVD P2P PQQKQ PROAC PSQYO RIG RKO RXVBD SV3 TEORI UJ6 UKHRP AAYXX ABBTS ABWCG ACQXL AFFHD AFSIO AHFRZ CITATION ITC PHGZM PHGZT PJZUB PPXIY CGR CUY CVF ECM EIF NPM 7TK 7XB 8FK K9. PKEHL PQEST PQUKI PRINS 7X8 PUEGO |
| ID | FETCH-LOGICAL-c400t-c12b7e317515b3b4a7514ded03304792de86b344dfcad91bd50679a72e22e9e13 |
| IEDL.DBID | 7X7 |
| ISICitedReferencesCount | 140 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000330857800010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1015-9770 1421-9786 |
| IngestDate | Wed Oct 01 13:51:49 EDT 2025 Fri Oct 03 11:10:18 EDT 2025 Mon Jul 21 05:57:18 EDT 2025 Sat Nov 29 08:01:10 EST 2025 Tue Nov 18 22:30:49 EST 2025 Thu Aug 29 12:04:44 EDT 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Biomarker Stroke Inflammation Lacunar stroke Endothelium |
| Language | English |
| License | Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. https://www.karger.com/Services/SiteLicenses 2013 S. Karger AG, Basel |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c400t-c12b7e317515b3b4a7514ded03304792de86b344dfcad91bd50679a72e22e9e13 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 ObjectType-Undefined-4 |
| PMID | 24401164 |
| PQID | 1512584441 |
| PQPubID | 34028 |
| PageCount | 12 |
| ParticipantIDs | crossref_citationtrail_10_1159_000356789 karger_primary_356789 proquest_journals_1512584441 crossref_primary_10_1159_000356789 proquest_miscellaneous_1493798437 pubmed_primary_24401164 |
| PublicationCentury | 2000 |
| PublicationDate | 2014-01-01 |
| PublicationDateYYYYMMDD | 2014-01-01 |
| PublicationDate_xml | – month: 01 year: 2014 text: 2014-01-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Basel, Switzerland |
| PublicationPlace_xml | – name: Basel, Switzerland – name: Switzerland – name: Basel |
| PublicationTitle | Cerebrovascular diseases (Basel, Switzerland) |
| PublicationTitleAlternate | Cerebrovasc Dis |
| PublicationYear | 2014 |
| Publisher | S. Karger AG |
| Publisher_xml | – name: S. Karger AG |
| References | Kataoka S, Hirose G, Hori A, Shirakawa T, Saigan T: Activation of thrombosis and fibrinolysis following brain infarction. J Neurol Sci 2000;181:82-88.1109971610.1016%2FS0022-510X%2800%2900435-4 Takano K, Yamaguchi T, Uchida K: Markers of a hypercoagulable state following acute ischemic stroke. Stroke 1992;23:194-198.156164710.1161%2F01.STR.23.2.194 Potter GM, Marlborough FJ, Wardlaw JM: Wide variation in definition, detection, and description of lacunar lesions on imaging. Stroke 2011;42:359-366.2119375210.1161%2FSTROKEAHA.110.594754 Beer C, Blacker D, Hankey GJ, Puddey IB: Association of clinical and aetiologic subtype of acute ischaemic stroke and inflammation, oxidative stress and vascular function: a cross-sectional observational study. Med Sci Monit 2011;17:467-473.10.12659%2FMSM.881931 Hasan N, McColgan P, Bentley P, Edwards RJ, Sharma P: Towards the identification of blood biomarkers for acute stroke in humans: a comprehensive systematic review. Br J Clin Pharmacol 2012;74:230-240.2232031310.1111%2Fj.1365-2125.2012.04212.x Montaner J, Perea-Gainza M, Delgado P, Ribó M, Chacón P, Rosell A, Quintana M, Palacios ME, Molina CA, Alvarez-Sabín J: Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Stroke 2008;39:2280-2287.1853528410.1161%2FSTROKEAHA.107.505354 Eikelboom JW, Hankey GJ, Anand SS, Lofthouse E, Staples N, Baker RI: Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke. Stroke 2000;31:1069-1075.1079716710.1161%2F01.STR.31.5.1069 Jood K, Danielson J, Ladenvall C, Blomstrand C, Jern C: Fibrinogen gene variation and ischemic stroke. J Thromb Haemost 2008;6:897-904.1833145310.1111%2Fj.1538-7836.2008.02950.x Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB: Meta-analysis of observational studies. JAMA 2000;283:2008-2012.1078967010.1001%2Fjama.283.15.2008 Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O'Brien JT, Barkhof F, Benavente OR, Black SE, Brayne C, Breteler M, Chabriat H, Decarli C, et al: Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013;12:822-838.2386720010.1016%2FS1474-4422%2813%2970124-8 Brouns R, Van den Bossche J, De Surgeloose D, Sheorajpanday R, De Deyn PP: Clinical and biochemical diagnosis of small-vessel disease in acute ischemic stroke. J Neurol Sci 2009;285:185-190.1961988410.1016%2Fj.jns.2009.06.032 Nakase T, Yamazaki T, Ogura N, Suzuki A, Nagata K: The impact of inflammation on the pathogenesis and prognosis of ischemic stroke. J Neurol Sci 2008;271:104-109.1847971010.1016%2Fj.jns.2008.03.020 Tuttolomondo A, Di Sciacca R, Di Raimondo D, Serio A, D'Aguanno G, La Placa S, Pecoraro R, Arnao V, Marino L, Monaco S, Natalè E, Licata G, Pinto A: Plasma levels of inflammatory and thrombotic/fibrinolytic markers in acute ischemic strokes: relationship with TOAST subtype, outcome and infarct site. J Neuroimmunol 2009;215:84-89.1969571610.1016%2Fj.jneuroim.2009.06.019 Ladenvall C, Jood K, Blomstrand C, Nilsson S, Jern C, Ladenvall P: Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtype. Stroke 2006;37:2018-2023.1680955510.1161%2F01.STR.0000231872.86071.68 Tuttolomondo A, Pinto A, Corrao S, Di Raimondo D, Fernandez P, Di Sciacca R, Arnao V, Licata G: Immuno-inflammatory and thrombotic/fibrinolytic variables associated with acute ischemic stroke diagnosis. Atherosclerosis 2009;203:503-508.1871556310.1016%2Fj.atherosclerosis.2008.06.030 Moher D, Liberati A, Tetzlaff J, Altman DG: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.1962107210.1371%2Fjournal.pmed.1000097 Yokokawa H, Goto A, Terui K, Funami Y, Watanabe K, Yasumura S: Prevalence of metabolic syndrome and serum marker levels in patients with four subtypes of cerebral infarction in Japan. J Clin Neurosci 2008;15:769-773.1841105010.1016%2Fj.jocn.2006.11.012 Jood K, Ladenvall P, Tjärnlund-Wolf A, Ladenvall C, Andersson M, Nilsson S, Blomstrand C, Jern C: Fibrinolytic gene polymorphism and ischemic stroke. Stroke 2005;36:2077-2081.1617956810.1161%2F01.STR.0000183617.54752.69 Jeong S-K, Kim D-H, Cho YI: Homocysteine and pulsatility index in lacunar infarction. Clin Neurol Neurosurg 2011;113:459-463.2137181710.1016%2Fj.clineuro.2011.01.016 Guldiken B, Guldiken S, Turgut B, Turgut N, Demir M, Celik Y, Arikan E, Tugrul A: The roles of oxidized low-density lipoprotein and interleukin-6 levels in acute atherothrombotic and lacunar ischemic stroke. Angiology 2008;59:224-229.1838804310.1177%2F0003319707304134 Chei C-L, Yamagishi K, Kitamura A, Kiyama M, Imano H, Ohira T, Tanigawa T, Sankai T, Ishikawa Y, Sato S, Iso H: C-reactive protein levels and risk of stroke and its subtype in Japanese: the Circulatory Risk in Communities Study (CIRCS). Atherosclerosis 2011;217:187-193.2144408610.1016%2Fj.atherosclerosis.2011.03.001 Iso H, Moriyama Y, Sato S, Kitamura A, Tanigawa T, Yamagishi K, Imano H, Ohira T, Okamura T, Naito Y, Shimamoto T: Serum total homocysteine concentrations and risk of stroke and its subtypes in Japanese. Circulation 2004;109:2766-2772.1515928710.1161%2F01.CIR.0000131942.77635.2D McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM: Reporting Recommendations for Tumour Marker Prognostic Studies (REMARK). Eur J Cancer 2005;41:1690-1696.1604334610.1016%2Fj.ejca.2005.03.032 Turgut B, Turgut N, Celik Y, Tekgündüz E, Pamuk GE, Demir M: Differences in platelet-leukocyte aggregates among subtypes of acute cerebral ischemia. J Neurol Sci 2011;305:126-130.2144026110.1016%2Fj.jns.2011.02.026 Hassan A, Hunt BJ, O'Sullivan M, Bell R, D'Souza R, Jeffery S, Bamford JM, Markus HS: Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain 2004;127:212-219.1460779110.1093%2Fbrain%2Fawh023 Ageno W, Finazzi S, Steidl L, Biotti MG, Mera V, Melzi D'Eril G, Venco A: Plasma measurement of D-dimer levels for the early diagnosis of ischemic stroke subtypes. Arch Intern Med 2002;162:2589-2593.1245623110.1001%2Farchinte.162.22.2589 Andersson J, Johansson L, Ladenvall P, Wiklund P-G, Stegmayr B, Jern C, Boman K: C-reactive protein is a determinant of first-ever stroke: prospective nested case-referent study. Cerebrovasc Dis 2009;27:544-551.1939017910.1159%2F000214217 Bath PMW, Blann A, Smith N, Butterworth RJ: Von Willebrand factor, P-selectin and fibrinogen levels in patients with acute ischaemic and haemorrhagic stroke, and their relationship with stroke sub-type and functional outcome. Platelets 1998;9:155-159.1679369410.1080%2F09537109876618 Mischak H, Allmaier G, Apweiler R, Attwood T, Baumann M, Benigni A, Bennett SE, Bischoff R, Bongcam-Rudloff E, Capasso G, Coon JJ, D'Haese P, Dominiczak AF, Dakna M, Dihazi H, et al: Recommendations for biomarker identification and qualification in clinical proteomics. Sci Transl Med 2010;2:46ps42.10.1126%2Fscitranslmed.3001249 Castellanos M, Castillo J, Garcia MM, Leira R, Serena J, Chamorro A, Davalos A: Inflammation-mediated damage in progressing lacunar infarctions: a potential therapeutic target. Stroke 2002;33:982-987.1193504810.1161%2Fhs0402.105339 Fassbender K, Rossol S, Kammer T, Daffertshofer M, Wirth S, Dollman M, Hennerici M: Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. J Neurol Sci 1994;122:135-139.802169510.1016%2F0022-510X%2894%2990289-5 Hassan A, Hunt BJ, O'Sullivan M, Parmar K, Bamford JM, Briley D, Brown MM, Thomas DJ, Markus HS: Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain 2003;126:424-432.1253840810.1093%2Fbrain%2Fawg040 Stevenson SF, Doubal FN, Shuler K, Wardlaw JM: A systematic review of dynamic cerebral and peripheral endothelial function in lacunar stroke versus controls. Stroke 2010;41:e434-e442.2039561910.1161%2FSTROKEAHA.109.569855 Domac FM, Somay G, Misirli H, Erenoglu NY: Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke. Neurosciences 2007;12:25-30. Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Rev Esp Salud Publica 2007;82:251-259. Supanc V, Biloglav Z, Kes VB, Demarin V: Role of cell adhesion molecules in acute ischemic stroke. Ann Saudi Med 2011;31:365-370.2180811210.4103%2F0256-4947.83217 Alvarez-Perez FJ, Castelo-Branco M, Alvarez-Sabin J: Usefulness of measurement of fibrinogen, D-dimer, D-dimer/fibrinogen ratio, C-reactive protein and erythrocyte sedimentation rate to assess the pathophysiology and mechanism of ischaemic stroke. J Neurol Neurosurg Psychiatry 2011;82:986-992.2129690010.1136%2Fjnnp.2010.230870 Isenegger J, Meier N, Lämmle B, Alberio L, Fischer U, Nedeltchev K, Gralla J, Kohler H-P, Mattle HP, Arnold M: D-dimers predict stroke subtype when assessed early. Cerebrovasc Dis 2010;29:82-86.1990716810.1159%2F000256652 Kilpatrick TJ, Matkovic Z, Davis SM, McGrath CM, Dauer RJ: Hematologic abnormalities occur in both cortical and lacunar infarction. Stroke 1993;24:1945-1950.824897710.1161%2F01.STR.24.12.1945 Ilhan D, Ozbabalik D, Gulcan E, Ozdemir O, Gülbaçs Z: Evaluation of platelet activation, coagulation, and fibrinolytic activation in patients with symptomatic lacunar stroke. Neurologist 2010;16:188-191.2044542810.1097%2FNRL.0b013e318198d8bc Vila N, Castillo J, Davalos A, Chamorro A: Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 2000;31:2325-2329.1102205810.1161%2F01.STR.31.10.2325 Beamer NB, Coull BM, Clark WM, Hazel JS, Silberger JR: Interleukin-6 and interleukin-1 antagonist in acute stroke. Ann Neurol 1995;37:800-805.777885410.1002%2Fana.41037061 ref13 ref12 ref56 ref15 ref14 ref53 ref52 ref11 ref55 ref10 ref54 ref17 ref16 ref19 ref18 ref51 ref50 ref46 ref45 ref48 ref47 ref42 ref41 ref44 ref43 ref49 ref8 ref7 ref9 ref4 ref3 ref6 ref5 ref40 ref35 ref34 ref37 ref36 ref31 ref30 ref33 ref32 ref2 ref1 ref39 ref38 ref24 ref23 ref26 ref25 ref20 ref22 ref21 ref28 ref27 ref29 |
| References_xml | – reference: Castellanos M, Castillo J, Garcia MM, Leira R, Serena J, Chamorro A, Davalos A: Inflammation-mediated damage in progressing lacunar infarctions: a potential therapeutic target. Stroke 2002;33:982-987.1193504810.1161%2Fhs0402.105339 – reference: McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM: Reporting Recommendations for Tumour Marker Prognostic Studies (REMARK). Eur J Cancer 2005;41:1690-1696.1604334610.1016%2Fj.ejca.2005.03.032 – reference: Brouns R, Van den Bossche J, De Surgeloose D, Sheorajpanday R, De Deyn PP: Clinical and biochemical diagnosis of small-vessel disease in acute ischemic stroke. J Neurol Sci 2009;285:185-190.1961988410.1016%2Fj.jns.2009.06.032 – reference: Parnetti L, Caso V, Santucci a A, Corea F, Lanari A, Floridi A, Conte C, Bottiglieri T: Mild hyperhomocysteinemia is a risk factor in all etiological subtypes of stroke. Neurol Sci 2004;25:13-17.1506081010.1007%2Fs10072-004-0219-5 – reference: Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Rev Esp Salud Publica 2007;82:251-259. – reference: Mischak H, Allmaier G, Apweiler R, Attwood T, Baumann M, Benigni A, Bennett SE, Bischoff R, Bongcam-Rudloff E, Capasso G, Coon JJ, D'Haese P, Dominiczak AF, Dakna M, Dihazi H, et al: Recommendations for biomarker identification and qualification in clinical proteomics. Sci Transl Med 2010;2:46ps42.10.1126%2Fscitranslmed.3001249 – reference: Tuttolomondo A, Di Sciacca R, Di Raimondo D, Serio A, D'Aguanno G, La Placa S, Pecoraro R, Arnao V, Marino L, Monaco S, Natalè E, Licata G, Pinto A: Plasma levels of inflammatory and thrombotic/fibrinolytic markers in acute ischemic strokes: relationship with TOAST subtype, outcome and infarct site. J Neuroimmunol 2009;215:84-89.1969571610.1016%2Fj.jneuroim.2009.06.019 – reference: Licata G, Tuttolomondo A, Di Raimondo D, Corrao S, Di Sciacca R, Pinto A: Immuno-inflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischaemic stroke. Thromb Haemost 2009:929-937.19404547 – reference: Tsai N-W, Chang W-N, Shaw C-F, Jan C-R, Chang H-W, Huang C-R, Chen S-D, Chuang Y-C, Lee L-H, Wang H-C, Lee T-H, Lu C-H: Levels and value of platelet activation markers in different subtypes of acute non-cardioembolic ischemic stroke. Thromb Res 2009;124:213-218.1923344910.1016%2Fj.thromres.2009.01.012 – reference: Knottnerus IL, Ten Cate H, Lodder J, Kessels F, Van Oostenbrugge RJ: Endothelial dysfunction in lacunar stroke: a systematic review. Cerebrovasc Dis 2009;27:519-526.1937265410.1159%2F000212672 – reference: Pavlovic AM, Pekmezovic T, Obrenovic R, Novakovic I, Tomic G, Mijajlovic M, Sternic N: Increased total homocysteine level is associated with clinical status and severity of white matter changes in symptomatic patients with subcortical small vessel disease. Clin Neurol Neurosurg 2011;113:711-715.2180219910.1016%2Fj.clineuro.2011.07.004 – reference: Alvarez-Perez FJ, Castelo-Branco M, Alvarez-Sabin J: Usefulness of measurement of fibrinogen, D-dimer, D-dimer/fibrinogen ratio, C-reactive protein and erythrocyte sedimentation rate to assess the pathophysiology and mechanism of ischaemic stroke. J Neurol Neurosurg Psychiatry 2011;82:986-992.2129690010.1136%2Fjnnp.2010.230870 – reference: Turgut B, Turgut N, Celik Y, Tekgündüz E, Pamuk GE, Demir M: Differences in platelet-leukocyte aggregates among subtypes of acute cerebral ischemia. J Neurol Sci 2011;305:126-130.2144026110.1016%2Fj.jns.2011.02.026 – reference: Moher D, Liberati A, Tetzlaff J, Altman DG: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.1962107210.1371%2Fjournal.pmed.1000097 – reference: Khan U, Hassan A, Vallance P, Markus HS: Asymmetric dimethylarginine in cerebral small vessel disease. Stroke 2007;38:411-413.1720468710.1161%2F01.STR.0000254500.27412.ac – reference: Beamer NB, Coull BM, Clark WM, Hazel JS, Silberger JR: Interleukin-6 and interleukin-1 antagonist in acute stroke. Ann Neurol 1995;37:800-805.777885410.1002%2Fana.410370614 – reference: Salobir B, Sabovic M, Peternel P, Stegnar M, Grad A: Classic risk factors, hypercoagulability and migraine in young women with cerebral lacunar infarctions. Acta Neurol Scand 2002;105:189-195.1188636310.1034%2Fj.1600-0404.2002.1o108.x – reference: Ilhan D, Ozbabalik D, Gulcan E, Ozdemir O, Gülbaçs Z: Evaluation of platelet activation, coagulation, and fibrinolytic activation in patients with symptomatic lacunar stroke. Neurologist 2010;16:188-191.2044542810.1097%2FNRL.0b013e318198d8bc – reference: Fassbender K, Rossol S, Kammer T, Daffertshofer M, Wirth S, Dollman M, Hennerici M: Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. J Neurol Sci 1994;122:135-139.802169510.1016%2F0022-510X%2894%2990289-5 – reference: Tuttolomondo A, Pinto A, Corrao S, Di Raimondo D, Fernandez P, Di Sciacca R, Arnao V, Licata G: Immuno-inflammatory and thrombotic/fibrinolytic variables associated with acute ischemic stroke diagnosis. Atherosclerosis 2009;203:503-508.1871556310.1016%2Fj.atherosclerosis.2008.06.030 – reference: Supanc V, Biloglav Z, Kes VB, Demarin V: Role of cell adhesion molecules in acute ischemic stroke. Ann Saudi Med 2011;31:365-370.2180811210.4103%2F0256-4947.83217 – reference: Khan U, Crossley C, Kalra L, Rudd A, Wolfe CDA, Collinson P, Markus HS: Homocysteine and its relationship to stroke subtypes in a UK black population: the south London ethnicity and stroke study. Stroke 2008;39:2943-2949.1875728910.1161%2FSTROKEAHA.107.513416 – reference: Andersson J, Johansson L, Ladenvall P, Wiklund P-G, Stegmayr B, Jern C, Boman K: C-reactive protein is a determinant of first-ever stroke: prospective nested case-referent study. Cerebrovasc Dis 2009;27:544-551.1939017910.1159%2F000214217 – reference: Ahmad O, Wardlaw J, Whiteley WN: Correlation of levels of neuronal and glial markers with radiological measures of infarct volume in ischaemic stroke: a systematic review. Cerebrovasc Dis 2012;33:47-54.2213384410.1159%2F000332810 – reference: Kataoka S, Hirose G, Hori A, Shirakawa T, Saigan T: Activation of thrombosis and fibrinolysis following brain infarction. J Neurol Sci 2000;181:82-88.1109971610.1016%2FS0022-510X%2800%2900435-4 – reference: Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB: Meta-analysis of observational studies. JAMA 2000;283:2008-2012.1078967010.1001%2Fjama.283.15.2008 – reference: Hassan A, Hunt BJ, O'Sullivan M, Bell R, D'Souza R, Jeffery S, Bamford JM, Markus HS: Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain 2004;127:212-219.1460779110.1093%2Fbrain%2Fawh023 – reference: Beer C, Blacker D, Hankey GJ, Puddey IB: Association of clinical and aetiologic subtype of acute ischaemic stroke and inflammation, oxidative stress and vascular function: a cross-sectional observational study. Med Sci Monit 2011;17:467-473.10.12659%2FMSM.881931 – reference: Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O'Brien JT, Barkhof F, Benavente OR, Black SE, Brayne C, Breteler M, Chabriat H, Decarli C, et al: Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013;12:822-838.2386720010.1016%2FS1474-4422%2813%2970124-8 – reference: Potter GM, Marlborough FJ, Wardlaw JM: Wide variation in definition, detection, and description of lacunar lesions on imaging. Stroke 2011;42:359-366.2119375210.1161%2FSTROKEAHA.110.594754 – reference: Lindgren A, Lindoff C, Norrving B, Astedt B, Johansson BB: Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients. Stroke 1996;27:1066-1071.865071610.1161%2F01.STR.27.6.1066 – reference: Eikelboom JW, Hankey GJ, Anand SS, Lofthouse E, Staples N, Baker RI: Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke. Stroke 2000;31:1069-1075.1079716710.1161%2F01.STR.31.5.1069 – reference: Vila N, Castillo J, Davalos A, Chamorro A: Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 2000;31:2325-2329.1102205810.1161%2F01.STR.31.10.2325 – reference: Hassan A, Hunt BJ, O'Sullivan M, Parmar K, Bamford JM, Briley D, Brown MM, Thomas DJ, Markus HS: Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain 2003;126:424-432.1253840810.1093%2Fbrain%2Fawg040 – reference: Guldiken B, Guldiken S, Turgut B, Turgut N, Demir M, Celik Y, Arikan E, Tugrul A: The roles of oxidized low-density lipoprotein and interleukin-6 levels in acute atherothrombotic and lacunar ischemic stroke. Angiology 2008;59:224-229.1838804310.1177%2F0003319707304134 – reference: Bath PMW, Blann A, Smith N, Butterworth RJ: Von Willebrand factor, P-selectin and fibrinogen levels in patients with acute ischaemic and haemorrhagic stroke, and their relationship with stroke sub-type and functional outcome. Platelets 1998;9:155-159.1679369410.1080%2F09537109876618 – reference: Takano K, Yamaguchi T, Uchida K: Markers of a hypercoagulable state following acute ischemic stroke. Stroke 1992;23:194-198.156164710.1161%2F01.STR.23.2.194 – reference: Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.767818410.1161%2F01.STR.24.1.35 – reference: Ageno W, Finazzi S, Steidl L, Biotti MG, Mera V, Melzi D'Eril G, Venco A: Plasma measurement of D-dimer levels for the early diagnosis of ischemic stroke subtypes. Arch Intern Med 2002;162:2589-2593.1245623110.1001%2Farchinte.162.22.2589 – reference: Ladenvall C, Jood K, Blomstrand C, Nilsson S, Jern C, Ladenvall P: Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtype. Stroke 2006;37:2018-2023.1680955510.1161%2F01.STR.0000231872.86071.68 – reference: Jood K, Danielson J, Ladenvall C, Blomstrand C, Jern C: Fibrinogen gene variation and ischemic stroke. J Thromb Haemost 2008;6:897-904.1833145310.1111%2Fj.1538-7836.2008.02950.x – reference: Chei C-L, Yamagishi K, Kitamura A, Kiyama M, Imano H, Ohira T, Tanigawa T, Sankai T, Ishikawa Y, Sato S, Iso H: C-reactive protein levels and risk of stroke and its subtype in Japanese: the Circulatory Risk in Communities Study (CIRCS). Atherosclerosis 2011;217:187-193.2144408610.1016%2Fj.atherosclerosis.2011.03.001 – reference: Higgins J, Greens S: Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 (available from www.cochrane-handbook.org). – reference: Kilpatrick TJ, Matkovic Z, Davis SM, McGrath CM, Dauer RJ: Hematologic abnormalities occur in both cortical and lacunar infarction. Stroke 1993;24:1945-1950.824897710.1161%2F01.STR.24.12.1945 – reference: Salobir B, Sabovic M: Possible vascular-bed-specific role of interleukin-6 in young women with a history of myocardial infarction, lacunar cerebral infarction and deep vein thrombosis. Cytokine 2004;25:265-272.1503624210.1016%2Fj.cyto.2003.11.011 – reference: Nakase T, Yamazaki T, Ogura N, Suzuki A, Nagata K: The impact of inflammation on the pathogenesis and prognosis of ischemic stroke. J Neurol Sci 2008;271:104-109.1847971010.1016%2Fj.jns.2008.03.020 – reference: Iso H, Moriyama Y, Sato S, Kitamura A, Tanigawa T, Yamagishi K, Imano H, Ohira T, Okamura T, Naito Y, Shimamoto T: Serum total homocysteine concentrations and risk of stroke and its subtypes in Japanese. Circulation 2004;109:2766-2772.1515928710.1161%2F01.CIR.0000131942.77635.2D – reference: Jood K, Ladenvall P, Tjärnlund-Wolf A, Ladenvall C, Andersson M, Nilsson S, Blomstrand C, Jern C: Fibrinolytic gene polymorphism and ischemic stroke. Stroke 2005;36:2077-2081.1617956810.1161%2F01.STR.0000183617.54752.69 – reference: Yokokawa H, Goto A, Terui K, Funami Y, Watanabe K, Yasumura S: Prevalence of metabolic syndrome and serum marker levels in patients with four subtypes of cerebral infarction in Japan. J Clin Neurosci 2008;15:769-773.1841105010.1016%2Fj.jocn.2006.11.012 – reference: Zhang B, Zhang W, Li X, Pu S, Yin J, Yang N, Yi Y, Gao Q, Gao C: Admission markers predict lacunar and non-lacunar stroke in young patients. Thromb Res 2011;128:14-17.2142956610.1016%2Fj.thromres.2011.02.020 – reference: Jackson C, Sudlow C: Are lacunar strokes really different? A systematic review of differences in risk factor profiles between lacunar and nonlacunar infarcts. Stroke 2005;36:891-901.1576120610.1161%2F01.STR.0000157949.34986.30 – reference: Hasan N, McColgan P, Bentley P, Edwards RJ, Sharma P: Towards the identification of blood biomarkers for acute stroke in humans: a comprehensive systematic review. Br J Clin Pharmacol 2012;74:230-240.2232031310.1111%2Fj.1365-2125.2012.04212.x – reference: Domac FM, Somay G, Misirli H, Erenoglu NY: Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke. Neurosciences 2007;12:25-30. – reference: Jeong S-K, Kim D-H, Cho YI: Homocysteine and pulsatility index in lacunar infarction. Clin Neurol Neurosurg 2011;113:459-463.2137181710.1016%2Fj.clineuro.2011.01.016 – reference: Stevenson SF, Doubal FN, Shuler K, Wardlaw JM: A systematic review of dynamic cerebral and peripheral endothelial function in lacunar stroke versus controls. Stroke 2010;41:e434-e442.2039561910.1161%2FSTROKEAHA.109.569855 – reference: Hanson E, Jood K, Karlsson S, Nilsson S, Blomstrand C, Jern C: Plasma levels of von Willebrand factor in the etiologic subtypes of ischemic stroke. J Thromb Haemost 2011;9:275-281.2105477910.1111%2Fj.1538-7836.2010.04134.x – reference: Ohira T, Shahar E, Chambless LE, Rosamond WD, Mosley TH, Folsom AR: Risk factors for ischemic stroke subtypes: the Atherosclerosis Risk in Communities study. Stroke 2006;37:2493-2498.1693178310.1161%2F01.STR.0000239694.19359.88 – reference: Isenegger J, Meier N, Lämmle B, Alberio L, Fischer U, Nedeltchev K, Gralla J, Kohler H-P, Mattle HP, Arnold M: D-dimers predict stroke subtype when assessed early. Cerebrovasc Dis 2010;29:82-86.1990716810.1159%2F000256652 – reference: Kozuka K, Kohriyama T, Nomura E, Ikeda J, Kajikawa H, Nakamura S: Endothelial markers and adhesion molecules in acute ischemic stroke - sequential change and differences in stroke subtype. Atherosclerosis 2002;161:161-168.1188232810.1016%2FS0021-9150%2801%2900635-9 – reference: Montaner J, Perea-Gainza M, Delgado P, Ribó M, Chacón P, Rosell A, Quintana M, Palacios ME, Molina CA, Alvarez-Sabín J: Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Stroke 2008;39:2280-2287.1853528410.1161%2FSTROKEAHA.107.505354 – ident: ref19 doi: 10.1161%2Fhs0402.105339 – ident: ref21 doi: 10.1161%2F01.STR.27.6.1066 – ident: ref28 doi: 10.1080%2F09537109876618 – ident: ref32 doi: 10.12659%2FMSM.881931 – ident: ref50 doi: 10.1161%2F01.STR.31.10.2325 – ident: ref25 doi: 10.1016%2Fj.atherosclerosis.2008.06.030 – ident: ref14 doi: 10.1161%2F01.STR.0000239694.19359.88 – ident: ref7 doi: 10.1016%2Fj.ejca.2005.03.032 – ident: ref27 doi: 10.1097%2FNRL.0b013e318198d8bc – ident: ref15 doi: 10.1159%2F000214217 – ident: ref33 doi: 10.1016%2Fj.thromres.2011.02.020 – ident: ref24 doi: 10.1016%2Fj.jneuroim.2009.06.019 – ident: ref35 doi: 10.1001%2Farchinte.162.22.2589 – ident: ref4 doi: 10.1371%2Fjournal.pmed.1000097 – ident: ref3 doi: 10.1111%2Fj.1365-2125.2012.04212.x – ident: ref36 doi: 10.1161%2FSTROKEAHA.107.505354 – ident: ref17 doi: 10.1161%2F01.STR.24.1.35 – ident: ref55 doi: 10.1016%2F0022-510X%2894%2990289-5 – ident: ref38 doi: 10.1159%2F000256652 – ident: ref22 doi: 10.1034%2Fj.1600-0404.2002.1o108.x – ident: ref2 doi: 10.1161%2FSTROKEAHA.109.569855 – ident: ref47 doi: 10.4103%2F0256-4947.83217 – ident: ref44 doi: 10.1016%2Fj.thromres.2009.01.012 – ident: ref45 doi: 10.1016%2Fj.jns.2011.02.026 – ident: ref13 doi: 10.1161%2F01.CIR.0000131942.77635.2D – ident: ref40 doi: 10.1161%2F01.STR.0000254500.27412.ac – ident: ref41 doi: 10.1016%2Fj.clineuro.2011.01.016 – ident: ref5 doi: 10.1001%2Fjama.283.15.2008 – ident: ref29 doi: 10.1016%2FS0022-510X%2800%2900435-4 – ident: ref26 doi: 10.1016%2Fj.jocn.2006.11.012 – ident: ref10 doi: 10.1161%2F01.STR.31.5.1069 – ident: ref6 doi: 10.1126%2Fscitranslmed.3001249 – ident: ref11 doi: 10.1093%2Fbrain%2Fawh023 – ident: ref12 doi: 10.1111%2Fj.1538-7836.2010.04134.x – ident: ref30 doi: 10.1111%2Fj.1538-7836.2008.02950.x – ident: ref8 doi: 10.1161%2FSTROKEAHA.107.513416 – ident: ref56 doi: 10.1159%2F000332810 – ident: ref9 doi: 10.1016%2FS1474-4422%2813%2970124-8 – ident: ref34 doi: 10.1161%2F01.STR.23.2.194 – ident: ref51 doi: 10.1016%2Fj.cyto.2003.11.011 – ident: ref53 doi: 10.1161%2FSTROKEAHA.110.594754 – ident: ref1 doi: 10.1159%2F000212672 – ident: ref48 doi: 10.1161%2F01.STR.0000231872.86071.68 – ident: ref54 doi: 10.1161%2F01.STR.0000157949.34986.30 – ident: ref20 doi: 10.1002%2Fana.410370614 – ident: ref42 doi: 10.1016%2Fj.clineuro.2011.07.004 – ident: ref52 doi: 10.1177%2F0003319707304134 – ident: ref16 doi: 10.1016%2Fj.atherosclerosis.2011.03.001 – ident: ref37 doi: 10.1016%2Fj.jns.2009.06.032 – ident: ref39 doi: 10.1007%2Fs10072-004-0219-5 – ident: ref43 doi: 10.1016%2FS0021-9150%2801%2900635-9 – ident: ref23 doi: 10.1161%2F01.STR.0000183617.54752.69 – ident: ref31 doi: 10.1136%2Fjnnp.2010.230870 – ident: ref49 doi: 10.1016%2Fj.jns.2008.03.020 – ident: ref46 doi: 10.1093%2Fbrain%2Fawg040 – ident: ref18 doi: 10.1161%2F01.STR.24.12.1945 |
| SSID | ssj0006181 |
| Score | 2.4664502 |
| SecondaryResourceType | review_article |
| Snippet | Background: The cause of cerebral small vessel disease is not fully understood, yet it is important, accounting for about 25% of all strokes. It also increases... The cause of cerebral small vessel disease is not fully understood, yet it is important, accounting for about 25% of all strokes. It also increases the risk of... |
| SourceID | proquest pubmed crossref karger |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 64 |
| SubjectTerms | Biomarkers - blood Blood Coagulation Blood Proteins - analysis Brain Ischemia - blood Cell Adhesion Molecules - blood Cytokines - blood Endothelium, Vascular - physiopathology Fibrinolysis Homocysteine - blood Humans Inflammation - blood Review Stroke - classification Stroke, Lacunar - blood |
| Title | Blood Markers of Coagulation, Fibrinolysis, Endothelial Dysfunction and Inflammation in Lacunar Stroke versus Non-Lacunar Stroke and Non-Stroke: Systematic Review and Meta-Analysis |
| URI | https://karger.com/doi/10.1159/000356789 https://www.ncbi.nlm.nih.gov/pubmed/24401164 https://www.proquest.com/docview/1512584441 https://www.proquest.com/docview/1493798437 |
| Volume | 37 |
| WOSCitedRecordID | wos000330857800010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1421-9786 dateEnd: 20151130 omitProxy: false ssIdentifier: ssj0006181 issn: 1015-9770 databaseCode: BENPR dateStart: 19970101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Proquest Health and Medical Complete customDbUrl: eissn: 1421-9786 dateEnd: 20151130 omitProxy: false ssIdentifier: ssj0006181 issn: 1015-9770 databaseCode: 7X7 dateStart: 19970101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nb9QwEB1BWyEuLR8tLC2VQRw41Oom8a6dXhAtuwKJrioK0t4iJ3ZQ1cppkywS_4sf2BnHCQIBFy5RYk-sKB77Pc_YMwCvaKGjyrHkIjKaC-T0XE11zCNlEeAKI1WufbIJuVio5TI9Cwa3Jmyr7OdEP1GbqiAb-SEhE4Iloveb6xtOWaPIuxpSaNyFdUqbTbHz5XJYcCFU-SSlqHUTjjxnHCILIYIfehcaTtTpL3i0cUnbr-u_s02POvOt__3eB7AZ-CZ72ynIQ7hj3SO4dxo86o_hxzHtXGd0ZAeJIKtKdlLpryGn1wGb04kAV_m4JQds5gwd2LpCnWXvvjeEiSTGtDPsgytRubqDkOzCsY-6WDlds_O2ri4to90fq4YtKsd_q6GXqbh7PGLnQ2xp1jkuvMSpbTXvI6hsw5f57PPJex4yOfAC54iWF1GcS0tUJZrkSS403ghjzZisKTKNjVXTPBHClIU2aZSbCdm3tIxtHNvURskOrLnK2afAkiQdT3UZEa8QOsJfnMciR9JnpZ1qFY_gdd-fWRHCnFO2javML3cmaTZ0_QheDqLXXWyPPwltd0oxiPTle32_Z2HYN9nPTh_Bi6EaByx5YbSz1QplBDLCVIlEjuBJp1tD08i1yDEmnv278V24j7xNdJagPVhr65V9DhvFt_aiqff9GPBXtQ_rx7PF2adb5q4QoQ |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB6VUkEvPPsIFFgQSBy6arzeZG0khKBt1KhJhNQi5eauvWtUtVq3tgPqn-LED2TGLwQCbj1wi-3JHuzZ-b7ZeQG8JEcnSPuKS89oLpHT82CoBfcCiwCXGBXEuho2oWazYD4PPy7Bt7YWhtIqW5tYGWqTJXRGvkPIhGCJ6P3u4pLT1CiKrrYjNGq1OLRXX9FlK96O9_D7vhJitH-8e8CbqQI8QX0teeKJWFmCTW8Q-7HU-EMaa_rk2atQGBsMY19KkybahF5sBnTWopWwQtjQej6uewNuoh1XlEKm5p2Dh9BYDUVFLR9w5FX9ppMRMoadKmSHwBD-gn8rZ5Tunf-d3VYoN7r7v72fe3Cn4dPsfb0B7sOSdQ_g1rTJGHgI3z9QZj6jkiQkuixL2W6mPzczy7bZiCoeXFb1Zdlm-85QQdo57km2d1UQ5pMY086wsUtx89SFnuzUsYlOFk7n7KjMszPLKLtlUbBZ5vhvT-jPdLu-fMOOut7ZrA7MVBJTW2redohZg0_X8s7WYdllzm4C8_2wP9SpR7xJag8_aSxkjKTWKjvUgejB61Z_oqRp407TRM6jyp0bhFGnaj140Yle1L1L_iS0VithJ9Le32r1LGrMWhH9VLIePO8eo0GiKJN2NlugjETGGwbSVz3YqHW5Wxq5JAX-5KN_L_4Mbh8cTyfRZDw7fAyryFFlfeq1BctlvrBPYCX5Up4W-dNq_zE4uW6F_gGSqWny |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Blood+Markers+of+Coagulation%2C+Fibrinolysis%2C+Endothelial+Dysfunction+and+Inflammation+in+Lacunar+Stroke+versus+Non-Lacunar+Stroke+and+Non-Stroke%3A+Systematic+Review+and+Meta-Analysis&rft.jtitle=Cerebrovascular+diseases+%28Basel%2C+Switzerland%29&rft.au=Wiseman%2C+Stewart&rft.au=Marlborough%2C+Fergal&rft.au=Doubal%2C+Fergus&rft.au=Webb%2C+David+J.&rft.date=2014-01-01&rft.issn=1015-9770&rft.eissn=1421-9786&rft.volume=37&rft.issue=1&rft.spage=64&rft.epage=75&rft_id=info:doi/10.1159%2F000356789&rft.externalDBID=n%2Fa&rft.externalDocID=10_1159_000356789 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1015-9770&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1015-9770&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1015-9770&client=summon |